• Home
  • News

Sichenzia Ross Ference LLP Represents Avinger Inc. in Close of $5.2 Million Underwritten Public Offering of Common Stock

avinger logo

Press Release – New York, NY – August 26, 2020 – Sichenzia Ross Ference LLP announced today that it represented Avinger, Inc. (NASDAQ: “AVGR”), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for diagnosis and treatment of patients with Peripheral Artery Disease (PAD), in a closing of an underwritten public offering of 11,063,830 shares of its common stock at a price of $0.47 per share. The offering was made pursuant to a shelf registration statement previously filed with and declared effective by the Securities and Exchange Commission (SEC).

Aegis Capital Corp. acted as sole bookrunner for the offering.

The Sichenzia Ross Ference LLP team was led by partners Gregory Sichenzia, Darrin Ocasio, Avital Perlman, and Barrett DiPaolo and associate Jacob Tabman.

Sichenzia Ross Ference LLP